Bioclones (Pty) Ltd
http://www.bioclones.co.za/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Bioclones (Pty) Ltd
Finance Watch: Investors Support Strategic Shifts At Cullinan, Cidara
Public Company Edition: Cullinan and Cidara shifted their strategic directions and found investors to bring along for the ride. Also, Intra-Cellular closed a post-Phase III $575m follow-on offering and Tarsus accessed up to $200m from Pharmakon.
Healios Acquires Bankrupt Athersys, Expands Cell Therapy R&D Programs
Tokyo-based Healios will lead the global clinical studies for Athersys’ cell therapy MultiStem for ARDS and start US Phase II trials for trauma following their long-term collaboration.
Alys Is An Asset Play Wanting Big Pharma Attention
Leaders of a new dermatology-focused biotech, which has launched with 14 development programs in its pipeline, explain the rationale behind the company creation and the ideal exit scenario.
Alys Puts Skin In The Dermatology Game With $100m Launch
Having adopted a similar model to set up Centessa, investment firm Medicxi is merging six of its portfolio companies to create an ambitious immuno-dermatology group.
Company Information
- Industry
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- Ribotech (Pty) Ltd
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice